| | | |  | | | | By Helen Branswell NIAID One official said the finding suggests international spread is wider, and has been occurring for longer than has been previously realized. Read More | | By Nicholas Florko Saul Loeb/AFP/Getty Images Biden is trying to unsnarl federal prisons' response to Covid, but experts say the latest moves also underscore just how much is still broken. Read More | | By Matthew Herper Courtesy Bristol Myers Squibb The acquisition gives Bristol a biotech that is developing medicines that fight cancer by targeting specific mutations. Read More | | Sponsor content by Astellas How can emerging biomarkers play a role in navigating the landscape of metastatic gastric cancer? Despite a landscape clouded in complexity, emerging biomarkers in metastatic gastric cancer are expanding our view of the disease, and biomarker testing could provide a more comprehensive patient profile. As these novel biomarkers, including Claudin 18.2 and FGFR2b, are better understood, they may reveal more opportunities to advance care for metastatic gastric cancer and gastroesophageal junction adenocarcinoma. Discover more about biomarkers and the potential impact they may have when utilized as part of a personalized medicine approach. | | By Lev Facher Michael Reynolds/Pool via AP Francis Collins thinks the debate surrounding the Biden administration’s new high-stakes research agency is much ado about nothing. Read More | | By Vineeta Gupta and Philippa Whitford Justin Sullivan/Getty Images The Global Financing Facility for Women, Children, and Adolescents provides a model to invest in the health of these groups. Read More | | By Allison DeAngelis and Jason Mast Adobe An IPO would suggest even in a record bear market Neumora thinks that public investors will have an appetite for the right company. Read More | |
No comments